SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-022682
Filing Date
2019-11-13
Accepted
2019-11-13 16:17:07
Documents
68
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20190930_10q.htm 10-Q 596519
2 EXHIBIT 31.1 ex_163732.htm EX-31.1 13617
3 EXHIBIT 31.2 ex_163733.htm EX-31.2 13584
4 EXHIBIT 32.1 ex_163734.htm EX-32.1 4821
5 EXHIBIT 32.2 ex_163735.htm EX-32.2 5366
12 untitled.jpg GRAPHIC 35435
  Complete submission text file 0001437749-19-022682.txt   3589350

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dmac-20190930.xml EX-101.INS 645030
7 XBRL TAXONOMY EXTENSION SCHEMA dmac-20190930.xsd EX-101.SCH 49417
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20190930_cal.xml EX-101.CAL 33643
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20190930_def.xml EX-101.DEF 288331
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20190930_lab.xml EX-101.LAB 247531
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20190930_pre.xml EX-101.PRE 314412
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 191214193
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences